Index by author

March 1, 2019; Volume 60,Issue 3

  1. Fani, Melpomeni

    1. Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog 177Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
      Alexander W. Sauter, Rosalba Mansi, Ulrich Hassiepen, Lionel Muller, Tania Panigada, Stefan Wiehr, Anna-Maria Wild, Susanne Geistlich, Martin Béhé, Christof Rottenburger, Damian Wild and Melpomeni Fani
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 393-399; DOI: https://doi.org/10.2967/jnumed.118.207845

  2. Flechsig, Paul

    1. Open Access
      68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
      Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner, Manfred M. Marschalek, Anastasia Loktev, Wencke Lehnert, Jürgen Debus, Dirk Jäger, Paul Flechsig, Annette Altmann, Walter Mier and Uwe Haberkorn
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.118.215913
    2. Open Access
      Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
      Frederik L. Giesel, Karina Knorr, Fabian Spohn, Leon Will, Tobias Maurer, Paul Flechsig, Oliver Neels, Kilian Schiller, Horacio Amaral, Wolfgang A. Weber, Uwe Haberkorn, Markus Schwaiger, Clemens Kratochwil, Peter Choyke, Vasko Kramer, Klaus Kopka and Matthias Eiber
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 362-368; DOI: https://doi.org/10.2967/jnumed.118.212233
Back to top

In this issue